Cite

HARVARD Citation

    Walzer, M. et al. (2020). Single‐ and Multiple‐Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies. Clinical pharmacology in drug development. 9 (3), pp. 297-306. [Online]. 
  
Back to record